Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 20/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1997975 | 1.00 | CHRM3 (0.55) | CHRM3CHRM2CHRM1 | |
| SCHEMBL1997731 | 0.86 | ALDH1A1 (0.52) | CHRM3CHRM2CHRM1 | |
| SCHEMBL1997749 | 0.86 | CHRM3 (0.64) | CHRM3CHRM2CHRM1 | |
| SCHEMBL2000222 | 0.83 | CHRM3 (0.55) | CHRM3CHRM2CHRM1 | |
| SCHEMBL1998248 | 0.83 | ALDH1A1 (0.55) | CHRM3CHRM2CHRM1 | |
| SCHEMBL9906136 | 0.82 | CHRM3 (0.58) | CHRM3CHRM2CHRM1 | |
| SCHEMBL1997996 | 0.82 | CHRM3 (0.58) | CHRM3CHRM2CHRM1 | |
| SCHEMBL12160546 | 0.82 | CHRM3 (0.67) | CHRM3CHRM2CHRM1 | |
| SCHEMBL2003623 | 0.82 | CHRM3 (0.57) | CHRM3CHRM2CHRM1 | |
| SCHEMBL2001705 | 0.82 | CHRM3 (0.57) | CHRM3CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101796026-B | Guanidine-containing compounds useful as muscarinic receptor antagonists | THERAVANCE INC | 2013-10-23 | — | — | CN | claimed |
| CN-101796026-A | Guanidine-containing compounds useful as muscarinic receptor antagonists | THERAVANCE INC | 2010-08-04 | — | — | CN | claimed |
| CN-101796026-B | Guanidine-containing compounds useful as muscarinic receptor antagonists | THERAVANCE INC | 2013-10-23 | — | — | CN | disclosed |
| CN-101796026-A | Guanidine-containing compounds useful as muscarinic receptor antagonists | THERAVANCE INC | 2010-08-04 | — | — | CN | disclosed |